Mastek hits new high on healthy June quarter results – Business Standard

Shares of rose 4 per cent to hit a new high of Rs 2,600 on the BSE in Tuesday’s intra-day trade as the firm reported a healthy set of June quarter (Q1FY22) numbers. The company’s dollar revenues increased 6.5 per cent quarter-on-quarter (QoQ) to $70.2 million. In constant currency terms, revenue grew 4.3 per cent. Rupee revenue increased 6.9 per cent QoQ to Rs 516.5 crore.

Ebitda (earnings before interest, taxes, depreciation, and amortisation) margins were flat QoQ at 21.8 per cent. Profit after tax (PAT) increased 14.4 per cent QoQ to Rs 69.3 crore. The management said despite an increase in costs due to onshoring, promotions and investments in talents during the quarter, the company has been able to maintain a healthy operating Ebitda margin.

The company said its 12-month order backlog was Rs 1,177.7 crore ($158.4mn) as on Q1FY22 as compared to Rs 1,130.4 crore ($154.6mn) in Q4FY21, reflecting a growth of 4.2 per cent in rupee terms and 2.1 per cent in constant currency terms, sequentially.

The company has seen a healthy deal pipeline and hiring has increased by 510 indicating healthy revenue visibility. Hence, analysts expect to report healthy revenue growth in the coming quarters.

In the past six months, the market price of has more than doubled and zoomed 120 per cent, as against a 4.6 per cent rise in the S&P BSE Sensex. At 11:47 am, the stock was trading 1 per cent higher at Rs 2,514 on the BSE, as compared to a 0.85 per cent decline in the benchmark index. A combined 390,000 shares had changed hands on the counter on the NSE and BSE so far.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Article Categories:
Health

Comments are closed.